SARAH MOBBS: Open Payments
NPI 1811401854 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,458 in 134 payments from 30 companies in 2025. Trend: 2023 $2,460 · 2024 $3,690 · 2025 $3,458
Food & beverage: $3,458
| Company | Payments | Amount |
|---|---|---|
| Inspire Medical Systems, Inc. | 8 | $604 |
| GlaxoSmithKline, LLC. | 19 | $381 |
| Regeneron Healthcare Solutions, Inc. | 15 | $335 |
| GENZYME CORPORATION | 10 | $319 |
| AstraZeneca Pharmaceuticals LP | 12 | $272 |
| Grifols USA, LLC | 9 | $198 |
| Viatris Specialty LLC | 7 | $168 |
| Amgen Inc. | 7 | $140 |
| Verona Pharma, Inc. | 5 | $121 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $104 |
Products named: DUPIXENT, INSPIRE, TEZSPIRE, NUCALA, Prolastin-C Liquid, YUPELRI, TRELEGY ELLIPTA, Ohtuvayre.
Industry payments across GA — which companies pay providers there.
